DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

Jurkovicova, Dana; Neophytou, Christiana M.; Čipak Gašparović, Ana; Gonçalves, Ana Cristina (2022) DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities. International Journal of Molecular Sciences, 23 (23). ISSN 1422-0067

PDF - Published Version - article Available under License Creative Commons Attribution. Download (672kB)

Abstract

Resistance to chemo- and radiotherapy is a common event among cancer patients and a reason why new cancer therapies and therapeutic strategies need to be in continuous investigation and development. DNA damage response (DDR) comprises several pathways that eliminate DNA damage to maintain genomic stability and integrity, but different types of cancers are associated with DDR machinery defects. Many improvements have been made in recent years, providing several drugs and therapeutic strategies for cancer patients, including those targeting the DDR pathways. Currently, poly (ADP-ribose) polymerase inhibitors (PARP inhibitors) are the DDR inhibitors (DDRi) approved for several cancers, including breast, ovarian, pancreatic, and prostate cancer. However, PARPi resistance is a growing issue in clinical settings that increases disease relapse and aggravate patients’ prognosis. Additionally, resistance to other DDRi is also being found and investigated. The resistance mechanisms to DDRi include reversion mutations, epigenetic modification, stabilization of the replication fork, and increased drug efflux. This review highlights the DDR pathways in cancer therapy, its role in the resistance to conventional treatments, and its exploitation for anticancer treatment. Biomarkers of treatment response, combination strategies with other anticancer agents, resistance mechanisms, and liabilities of treatment with DDR inhibitors are also discussed.

Item Type:	Article
Uncontrolled Keywords:	DNA damage response; drug resistance; DNA damage repair inhibitors; biomarkers
Subjects:	BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences
Divisions:	Division of Molecular Medicine
Depositing User:	Lorena Palameta
Date Deposited:	14 Jul 2026 09:32
URI:	https://fulir.irb.hr:/id/eprint/12054
DOI:	10.3390/ijms232314672

Actions (login required)

View Item